Cover Image
市場調查報告書

PharmaPoint:人類乳突病毒(HPV)預防疫苗 - 現在、未來的主要企業

PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players

出版商 GlobalData 商品編碼 307137
出版日期 內容資訊 英文 40 Pages
訂單完成後即時交付
價格
Back to Top
PharmaPoint:人類乳突病毒(HPV)預防疫苗 - 現在、未來的主要企業 PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players
出版日期: 2014年03月31日 內容資訊: 英文 40 Pages
簡介

本報告提供急速成長的人類乳突病毒(HPV)預防疫苗市場相關調查分析,包含新加入企業的競爭情形為焦點,市場預測,再加上主要企業簡介等相關有系統的資訊。

第1章 目錄

第2章 簡介

第3章 市場預測

  • 全球市場
    • 預測
    • 推動因素、障礙

第4章 現在、未來的主要企業

  • 概要
  • 企業策略趨勢
  • 企業簡介
    • Merck
    • GSK

第5章 附錄

圖表

目錄
Product Code: GDHC1032FPR

GlobalData has released its pharma report, "PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prophylactic Human Papillomavirus Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Prophylactic Human Papillomavirus Vaccines market. The report provides insight into the competitive Prophylactic Human Papillomavirus Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Prophylactic Human Papillomavirus Vaccines
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Prophylactic Human Papillomavirus Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving Prophylactic Human Papillomavirus Vaccines market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What's the next big thing in the global Prophylactic Human Papillomavirus Vaccines market landscape? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Market Outlook

  • 3.1. Global Markets
    • 3.1.1. Forecast
    • 3.1.2. Drivers and Barriers - Global Issues

4. Current and Future Players

  • 4.1. Overview
  • 4.2. Trends in Corporate Strategy
  • 4.3. Company Profiles
    • 4.3.1. Merck
    • 4.3.2. GSK

5. Appendix

  • 5.1. Bibliography
  • 5.2. Abbreviations
  • 5.3. Methodology
  • 5.4. Forecasting Methodology
    • 5.4.1. Vaccine Coverage
    • 5.4.2. Vaccine Approval versus Routine Schedule Inclusion
    • 5.4.3. General Pricing Assumptions
  • 5.5. Physicians and Specialists Included in this Study
  • 5.6. About the Author(s)
    • 5.6.1. Author(s)
    • 5.6.2. Therapy Area Director
    • 5.6.3. Global Head of Healthcare
  • 5.7. About GlobalData
  • 5.8. Disclaimer

List of Tables

  • Table 1: Global Sales Forecasts ($m) for HPV Vaccines, 2012-2022
  • Table 2: Global HPV Vaccine Market - Drivers and Barriers, 2014
  • Table 3: Key Companies in the HPV Vaccine Market, 2014
  • Table 4: Merck's HPV Vaccine Portfolio Assessment, 2014
  • Table 5: Merck SWOT Analysis, 2014
  • Table 6: GSK's HPV Vaccine Portfolio Assessment, 2014
  • Table 7: GSK SWOT Analysis, 2014
  • Table 8: High-Prescribing Physicians (non-KOLs) Surveyed, By Country

List of Figures

  • Figure 1: Global Sales for HPV Vaccines by Region, 2012-2022
  • Figure 2: Company Portfolio Gap Analysis in HPV Vaccines, 2012-2022
Back to Top